Health Care/Hospital
Cambrex Nears Completion of 5-year, $100-Million-Dollar Investment Plan, One Year Ahead of Schedule
EAST RUTHERFORD, N.J., March 18, 2024 /PRNewswire/ -- Cambrex, a leading global contract development and manufacturing organization (CDMO), announced today that it is nearing the completion of a 5-year,$100-million-dollar investment strategy, one year ahead of schedule. The project, which adds mo...
2024-03-18 18:00
1938
Everest Medicines Strengthens Management Team with Appointments of Chief Medical Officer and Chief Product Officer
SHANGHAI, March 18, 2024 /PRNewswire/ -- Everest Medicines (HKEX: 1952.HK, "Everest," or the "Company"), a biopharmaceutical company focused on the discovery, development, manufacturing and commercialization of innovative medicines and vaccines, today announced that the company has strengthened i...
2024-03-18 09:00
2360
Mediwave Earns Global Recognition at GLOMO Awards 2024 for Emergency Response HealthTech
SINGAPORE, March 17, 2024 /PRNewswire/ -- Mediwave, a leading-edge HealthTech company, was recognised as a finalist at the prestigious Global Mobile Awards (GLOMO), part of the Mobile World Congress (MWC) powered by GSMA inBarcelona, Spain. This acknowledgment underscores Mediwave's exceptional c...
2024-03-18 08:00
1447
Peer2Gether Foundation Celebrates Milestone of Supporting 50 Orphanages and Elderly Care Facilities
Peer2Gether Foundation has been able to expand its reach and support orphanages and elderly care facilities acrossSingapore SINGAPORE, March 16, 2024 /PRNewswire/ – Peer2Gether Foundation, a non-profit organization dedicated to supporting orphanages and the elderly, is proud to announce that it ...
2024-03-16 09:00
4400
SOPHiA GENETICS and The French Kidney Cancer Research Network (UroCCR) Publish Results from Multiyear Collaboration
New Multimodal Algorithm Highlights Predictive Benefit Of Artificial Intelligence (AI) for Cancer Research BOSTON and ROLLE, Switzerland, March 15, 2024 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, and the French Kidney Can...
2024-03-15 18:00
2569
/C O R R E C T I O N -- Sisram Medical Ltd/
In the news release, Sisram Medical to Report FY2023 Financial Results on March 20 and Hold a Conference Call on March 21, issued on 14-Mar-2024 by Sisram Medical Ltd over PR Newswire, we are advised by the company that regarding the time, specifically, the Israel Time, should read "2:00 p.m." ra...
2024-03-15 16:42
3142
Infinitus Leads in Innovation at FHE2024 with Groundbreaking Health Food Research
Demonstrating Technological Advances in Immunity-Boosting Complex Polysaccharides, the Company Sets New Standards for Functional Food Development GUANGZHOU, China, March 14, 2024 /PRNewswire/ – Infinitus (China) Company Ltd. was a participant in the 2024 Boao Food for Health Science Conference an...
2024-03-15 16:20
3409
Novartis expands its biopharmaceutical manufacturing site in Singapore
* Invests US$256 million to expand biopharmaceutical manufacturing facility in Singapore, addressing the soaring demand in the Asian market * Set to generate 100 high skilled employment opportunities in Singapore's life science industry SINGAPORE, March 15, 2024 /PRNewswire/ -- Novartis today...
2024-03-15 14:55
3631
Qilu Pharmaceutical Showcases QL1706 Clinical Trial Outcomes in Oral Presentation at ESGO 2024
JINAN, China, March 15, 2024 /PRNewswire/ -- On 8 March local time, during the 25th European Society of Gynecological Oncology (ESGO) Conference (ESGO 2024) in Spain, Qilu Pharmaceutical unveiled the Phase II clinical trial results for iparomlimab and tuvonralimab (QL1706) in an oral presentation....
2024-03-15 14:07
2611
ImmVira's oncolytic product MVR-T3011 IT Intratumoral Injection Receives FDA Fast Track Designation for HNSCC Treatment
SHENZHEN, China, March 15, 2024 /PRNewswire/ -- ImmVira has recently announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for oncolytic virus product MVR-T3011 IT (intratumoral injection) for the treatment of recurrent or metastatic head and neck squamous ...
2024-03-15 13:56
1628
Seegene and Springer Nature Announce Awardees for the Open Innovation Program
* 26 submissions selected from a total of 281 applications from 47 countries to diagnose infectious and vector-borne diseases * Awardees representing 12 countries in Europe, the Americas, Asia and Africa , will receive research grants of up toUSD 600,000 per project * As part of the Seegene's...
2024-03-15 13:41
2737
Biotheus Expanded Their Partnership with Hansoh Pharma for Developing EGFR/cMET Bispecific Antibody-Drug Conjugates
ZHUHAI, China, March 15, 2024 /PRNewswire/ -- On March 14, 2024, Biotheus Inc. (Biotheus), a clinical-stage biotech company focusing on the discovery and development of biologics for oncology and inflammatory diseases, and Hansoh Pharmaceutical Group Co., Ltd. (Hansoh Pharma,03692.HK), China's le...
2024-03-15 12:34
1544
CStone Announces the Fifth Indication Approved for Sugemalimab in China as First-Line Treatment for Gastric Cancer
* Sugemalimab is the world's first anti-PD-L1 monoclonal antibody approved for the treatment of gastric or gastroesophageal junction (G/GEJ) adenocarcinoma. * This marks the 13th NDA approval obtained by CStone and sugemalimab's fifth indication approved inChina, following stage III and IV no...
2024-03-15 12:10
2870
Angel Yeast Hosts Community Welfare Activity in Egypt, Promoting Green Development and Cultural Exchanges
SHANGHAI, March 15, 2024 /PRNewswire/ -- Angel Yeast
2024-03-15 09:04
3987
Advancing Healthcare in Uzbekistan: BGI Genomics CEO's Vision Shared on Uzbekistan's National Television
HONG KONG, March 15, 2024 /PRNewswire/ -- Zhao Lijian, CEO of BGI Genomics, provided fresh insights on the company's vision during an exclusive interview withUzbekistan's National Television on Channel O'zbekiston24. This discussion was part of the "Focusing on the History of Uzbekistan-China Rel...
2024-03-15 07:55
2693
I-Mab Reports Full Year 2023 Financial Results and Business Update
* Recently announced agreement to divest assets and business operations in China marks an important milestone for the Company; the transaction is expected to close by the end ofMarch 2024 * Uliledlimab (CD73 antibody) on track to file an IND in combination with chemotherapy and checkpoint inh...
2024-03-15 05:00
3434
Zeus Names New Chief Executive Officer
* Zeus, a leading supplier of custom polymer components to the world's most innovative medical device and industrial companies, names Padraic "Paddy" O'Brien as new CEO * O'Brien joins Zeus at a pivotal moment as the company enters a new chapter of growth under EQT ownership * O'Brien c...
2024-03-15 01:00
5339
D3 Bio Appoints Dr. Antoine Yver as Independent Board Member
SHANGHAI, March 14, 2024 /PRNewswire/ -- D3 Bio, an emerging global biotechnology company that focuses on discovery, development, and registration of innovative cancer drugs, welcomesAntoine Yver, MD. ,MSc. as the new independent board member, effectiveMarch 4, 2024. Dr. Yver has 34 years of e...
2024-03-14 22:30
1880
Lunit SCOPE AI Enhances Pathologist Concordance and Accuracy in HER2, ER, and PR Assessment - New Study in Breast Cancer Research
- Lunit SCOPE HER2 and Lunit SCOPE ER/PR significantly improve pathologist concordance and accuracy, paving the way for improved breast cancer molecular subtype analysis for informed decision-making and precision patient care SEOUL, South Korea, March 14, 2024 /PRNewswire/ -- Lunit (KRX:328130.KQ...
2024-03-14 21:00
1900
Virtus Medical Group Announces New Strategic Investors
Shanghai Healthcare Capital, along with Mitsui and MediTrust, invest in and partner strategically with Virtus, cementing Virtus'sLeadership in Private Healthcare Services, and Propelling Healthcare Innovation. HONG KONG, March 14, 2024 /PRNewswire/ -- Virtus Medical Holdings Limited ("Virtus Med...
2024-03-14 19:43
3227
Week's Top Stories
Most Reposted
QDX Co-Founder Giuseppe Barca Awarded Prestigious Gordon Bell Prize, Pioneering Advancements in Drug Discovery Technology
[Picked up by 303 media titles]
2024-11-26 18:49Southeast Asian Consumers Raise Online Security Concerns, New GSMA Survey Shows
[Picked up by 296 media titles]
2024-11-26 13:00ITAP 2024 sets the stage for a more connected advanced factory ecosystem with focus on AI, advanced robotics and sustainability
[Picked up by 296 media titles]
2024-11-28 17:24MediSun Energy Raises $8.75M Seed Round with Vynn Capital to Drive MENA Expansion and Advance Osmotic Energy Innovation
[Picked up by 280 media titles]
2024-11-25 10:00
Announcement of "Cyber Sousa Award" Winners of the 16th Xiamen International Animation Festival
[Picked up by 272 media titles]
2024-11-26 16:48
Most Read
Chinese path to modernization a model for Global South, experts say
2024-11-23 15:35
12324
SUNLU Formnext 2024 Event Highlights: From Functional Filaments to FilaDryer E2
2024-11-23 21:00
8375
Innovative technology and applications recognised with Hong Kong ICT Awards 2024
2024-11-23 02:02
8090
MMA SMARTIES Thailand 2024 - Celebrates Unparalleled Marketing Innovation and Excellence in Thailand
2024-11-23 11:00
7519
WeBank Powers Fusion Bank's Rapid Launch of a Next-Generation Core Banking System
2024-11-22 15:21
5841